480 related articles for article (PubMed ID: 23664655)
1. Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats.
Leys LJ; Chu KL; Xu J; Pai M; Yang HS; Robb HM; Jarvis MF; Radek RJ; McGaraughty S
Pain; 2013 Jul; 154(7):1092-102. PubMed ID: 23664655
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.
Joshi SK; Mikusa JP; Hernandez G; Baker S; Shieh CC; Neelands T; Zhang XF; Niforatos W; Kage K; Han P; Krafte D; Faltynek C; Sullivan JP; Jarvis MF; Honore P
Pain; 2006 Jul; 123(1-2):75-82. PubMed ID: 16545521
[TBL] [Abstract][Full Text] [Related]
3. Animal models of pain: best behavioral analysis for better translational research.
Araujo P; Tufik S; Andersen ML
Pain; 2013 Jul; 154(7):968-969. PubMed ID: 23680498
[No Abstract] [Full Text] [Related]
4. Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis.
Takemura Y; Yamashita A; Horiuchi H; Furuya M; Yanase M; Niikura K; Imai S; Hatakeyama N; Kinoshita H; Tsukiyama Y; Senba E; Matoba M; Kuzumaki N; Yamazaki M; Suzuki T; Narita M
Synapse; 2011 Jul; 65(7):668-76. PubMed ID: 21162109
[TBL] [Abstract][Full Text] [Related]
5. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.
Piesla MJ; Leventhal L; Strassle BW; Harrison JE; Cummons TA; Lu P; Whiteside GT
Brain Res; 2009 Oct; 1295():89-98. PubMed ID: 19651113
[TBL] [Abstract][Full Text] [Related]
6. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats.
Nagakura Y; Takahashi M; Noto T; Sekizawa T; Oe T; Yoshimi E; Tamaki K; Shimizu Y
Behav Brain Res; 2012 Jan; 226(1):242-9. PubMed ID: 21945299
[TBL] [Abstract][Full Text] [Related]
7. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain.
Honore P; Wade CL; Zhong C; Harris RR; Wu C; Ghayur T; Iwakura Y; Decker MW; Faltynek C; Sullivan J; Jarvis MF
Behav Brain Res; 2006 Feb; 167(2):355-64. PubMed ID: 16256210
[TBL] [Abstract][Full Text] [Related]
9. Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone.
Xu Y; Qiu HQ; Liu H; Liu M; Huang ZY; Yang J; Su YP; Yu CX
Pharmacol Biochem Behav; 2012 May; 101(3):504-14. PubMed ID: 22366214
[TBL] [Abstract][Full Text] [Related]
10. Anatomically specific patterns of glial activation in the periaqueductal gray of the sub-population of rats showing pain and disability following chronic constriction injury of the sciatic nerve.
Mor D; Bembrick AL; Austin PJ; Wyllie PM; Creber NJ; Denyer GS; Keay KA
Neuroscience; 2010 Apr; 166(4):1167-84. PubMed ID: 20109535
[TBL] [Abstract][Full Text] [Related]
11. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
[TBL] [Abstract][Full Text] [Related]
12. Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats.
Tétreault P; Dansereau MA; Doré-Savard L; Beaudet N; Sarret P
Physiol Behav; 2011 Sep; 104(3):495-502. PubMed ID: 21620878
[TBL] [Abstract][Full Text] [Related]
13. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
15. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?
Combe R; Bramwell S; Field MJ
Neurosci Lett; 2004 Nov; 370(2-3):236-40. PubMed ID: 15488329
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
17. Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition.
Xiao WH; Bennett GJ
Anesthesiology; 2007 Nov; 107(5):813-21. PubMed ID: 18073557
[TBL] [Abstract][Full Text] [Related]
18. Modality of hyperalgesia tested, not type of nerve damage, predicts pharmacological sensitivity in rat models of neuropathic pain.
Pradhan AA; Yu XH; Laird JM
Eur J Pain; 2010 May; 14(5):503-9. PubMed ID: 19963418
[TBL] [Abstract][Full Text] [Related]
19. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury.
Pedersen LH; Scheel-Krüger J; Blackburn-Munro G
Pain; 2007 Jan; 127(1-2):17-26. PubMed ID: 16965855
[TBL] [Abstract][Full Text] [Related]
20. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
Teodoro FC; Tronco Júnior MF; Zampronio AR; Martini AC; Rae GA; Chichorro JG
Neuropeptides; 2013 Jun; 47(3):199-206. PubMed ID: 23177733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
